Biotech Late Stage Investors & VC Firms

360 firms in this list, with a median first check of $1M. 82 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLSV11 people	88🔒	Contern	LU	Series B–Late Stage	$10.8M	+ Add to CRM
OO Oost NL JBSH2 people	88🔒	Apeldoorn	NL	Seed–Late Stage	$108K – $5.4M	+ Add to CRM
MO Mohr Davidow Ventures BSESKFBE7 people	88🔒	San Mateo	US	Seed–Late Stage	$200K – $4M	+ Add to CRM
UN Unfold Ventures JSAJACMS7 people	88🔒	Wrocław	PL	Pre-Seed–Late Stage	$110K – $1.1M	+ Add to CRM
CA Catapult Capital GCDLRM3 people	88🔒	San Francisco	US	Late Stage	$50M – $500M	+ Add to CRM
NO Novalis LifeSciences MDDLPMCG9 people	88🔒	Portsmouth	US	Seed–Late Stage	—	+ Add to CRM
GL Global BioAccess Fund BRLWTMSG7 people	88🔒	New York	US	Series A–Late Stage	$10M	+ Add to CRM
BI Birch Venture Capital, Inc. MWLLTH3 people	88🔒	Taipei City	TW	Seed–Late Stage	—	+ Add to CRM
LE Legendary Ventures, Llc. JDMLAKZD9 people	88🔒	New York City	US	Seed–Late Stage	—	+ Add to CRM
KE Kern Capital, LLC JK1 person · Leads rounds	88🔒	Larkspur	US	Series A–Late Stage	$5M – $15M	+ Add to CRM
SA Saffelberg Investments JSJGLOFH10 people	88🔒	Gooik	BE	Seed–Late Stage	—	+ Add to CRM
MS MSA Capital JZKQYXYZ6 people · Leads rounds	88🔒	Grand Cayman	CN	Pre-Seed–Late Stage	—	+ Add to CRM
QU Quest for Growth SLAPBDHF8 people	88🔒	Leuven	BE	Growth–Late Stage	—	+ Add to CRM
CC CC Trust Group AG DJBJDHGC10 people	88🔒	Baar	CH	Growth–Late Stage	—	+ Add to CRM
OC Octave Ventures Llc WSMSJSJ4 people	88🔒	Henderson	US	Seed–Late Stage	—	+ Add to CRM
WH Whiz Partners Inc. YH安俊藤朋HF6 people	88🔒	Tokyo	JP	Seed–Late Stage	$500K – $5M	+ Add to CRM
GO Good Startup GGJPCBPM5 people	88🔒	Brussels	SG	Seed–Late Stage	—	+ Add to CRM
AU Aurelia Foundry AEIEJLAA4 people	88🔒	Wellesley	US	Pre-Seed–Late Stage	—	+ Add to CRM
MA Matrix Partners China DSXLHM3 people · Leads rounds	88🔒	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
OD ODYSSEE VENTURE JAMBSS3 people	88🔒	Paris	FR	Series A–Late Stage	$1.1M – $11M	+ Add to CRM
MA Mayo Clinic Ventures AJPA2 people	88🔒	Rochester	US	Seed–Late Stage	—	+ Add to CRM
KO Kolon Investment, Inc.	88🔒	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
KI KittyHawk Ventures RMWW2 people · Leads rounds	88🔒	Silicon Valley	US	Seed–Late Stage	$250K – $15M	+ Add to CRM
GE Genii Capital	88🔒	Howald	LU	Growth–Late Stage	—	+ Add to CRM

Vesalius Biocapital III Partners SàRL

ConternSeries B–Late Stage$10.8M

CSGGMLSV11 people

Oost NL

ApeldoornSeed–Late Stage$108K – $5.4M

JBSH2 people

Mohr Davidow Ventures

San MateoSeed–Late Stage$200K – $4M

BSESKFBE7 people

Unfold Ventures

WrocławPre-Seed–Late Stage$110K – $1.1M

JSAJACMS7 people

Catapult Capital

San FranciscoLate Stage$50M – $500M

GCDLRM3 people

Novalis LifeSciences

PortsmouthSeed–Late Stage

MDDLPMCG9 people

Global BioAccess Fund

New YorkSeries A–Late Stage$10M

BRLWTMSG7 people

Birch Venture Capital, Inc.

Taipei CitySeed–Late Stage

MWLLTH3 people

Legendary Ventures, Llc.

New York CitySeed–Late Stage

JDMLAKZD9 people

Kern Capital, LLC

LarkspurSeries A–Late Stage$5M – $15M

JK1 person

Saffelberg Investments

GooikSeed–Late Stage

JSJGLOFH10 people

MSA Capital

Grand CaymanPre-Seed–Late Stage

JZKQYXYZ6 people

Quest for Growth

LeuvenGrowth–Late Stage

SLAPBDHF8 people

CC Trust Group AG

BaarGrowth–Late Stage

DJBJDHGC10 people

Octave Ventures Llc

HendersonSeed–Late Stage

WSMSJSJ4 people

Whiz Partners Inc.

TokyoSeed–Late Stage$500K – $5M

YH安俊藤朋HF6 people

Good Startup

BrusselsSeed–Late Stage

GGJPCBPM5 people

Aurelia Foundry

WellesleyPre-Seed–Late Stage

AEIEJLAA4 people

Matrix Partners China

BeijingSeed–Late Stage

DSXLHM3 people

ODYSSEE VENTURE

ParisSeries A–Late Stage$1.1M – $11M

JAMBSS3 people

Mayo Clinic Ventures

RochesterSeed–Late Stage

AJPA2 people

Kolon Investment, Inc.

SeoulSeed–Late Stage

KittyHawk Ventures

Silicon ValleySeed–Late Stage$250K – $15M

RMWW2 people

Genii Capital

HowaldGrowth–Late Stage

Data sourced from public filings and firms' own websites — see our methodology.